Literature DB >> 29357090

Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.

Yung-Chiang Liu1, I-Chi Lee2,3, Pin-Yuan Chen4,5,6.   

Abstract

Glioblastoma (GBM) is the most malignant primary brain tumor and contains tumorigenic cancer stem cells (CSCs), which support the progression of tumor growth. The selection of CSCs and facilitation of the brain tumor niches may assist the development of novel therapeutics for GBM. Herein, hydrogel materials composed of agarose and hydroxypropyl methyl cellulose (HMC) in different concentrations were established and compared to emulate brain tumor niches and CSC microenvironments within a label-free system. Human GBM cell line, U-87 MG, was cultured on a series of HMC-agarose based culture system. Cell aggregation and spheroids formation were investigated after 4 days of culture, and 2.5% HMC-agarose based culture system demonstrated the largest spheroids number and size. Moreover, CD133 marker expression of GBM cells after 6 days of culture in 2.5% HMC-agarose based culture system was 60%, relatively higher than the control group at only 15%. Additionally, cells on 2.5% HMC-agarose based culture system show the highest chemoresistance, even at the high dose of 500 µM temozolomide for 72 h, the live cell ratio was still > 80%. Furthermore, the results also indicate that the expression of ABCG2 gene was up-regulated after culture in 2.5% HMC-agarose based culture system. Therefore, our results demonstrated that biomimetic brain tumor microenvironment may regulate GBM cells towards the CSC phenotype and expression of CSC characteristics. The microenvironment selection and spheroids formation in HMC-agarose based culture system may provide a label-free CSC selection strategy and drug testing model for future biomedical applications.

Entities:  

Keywords:  Brain tumor niche; Cancer stem cells (CSCs); Drug resistance; Human glioblastoma cells; Hydroxypropyl methyl cellulose (HMC)

Mesh:

Substances:

Year:  2018        PMID: 29357090     DOI: 10.1007/s11060-018-2763-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

Review 2.  Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.

Authors:  J U Marquardt; V M Factor; S S Thorgeirsson
Journal:  J Hepatol       Date:  2010-05-31       Impact factor: 25.083

3.  Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.

Authors:  Takashi Shingu; Allen L Ho; Liang Yuan; Xin Zhou; Congxin Dai; Siyuan Zheng; Qianghu Wang; Yi Zhong; Qing Chang; James W Horner; Brandon D Liebelt; Yu Yao; Baoli Hu; Yiwen Chen; Gregory N Fuller; Roeland G W Verhaak; Amy B Heimberger; Jian Hu
Journal:  Nat Genet       Date:  2016-11-14       Impact factor: 38.330

4.  Cancer Stem Cells under Hypoxia as a Chemoresistance Factor in Breast and Brain.

Authors:  Spencer W Crowder; Daniel A Balikov; Yu-Shik Hwang; Hak-Joon Sung
Journal:  Curr Pathobiol Rep       Date:  2014-03

5.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Authors:  John M Heddleston; Zhizhong Li; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

Review 6.  The role of hypoxia in stem cell differentiation and therapeutics.

Authors:  Hamid Abdollahi; Lisa J Harris; Ping Zhang; Stephen McIlhenny; Vikram Srinivas; Thomas Tulenko; Paul J DiMuzio
Journal:  J Surg Res       Date:  2009-10-24       Impact factor: 2.192

7.  ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy.

Authors:  Fan Lin; Mark C de Gooijer; Eloy Moreno Roig; Levi C M Buil; Susan M Christner; Jan H Beumer; Thomas Würdinger; Jos H Beijnen; Olaf van Tellingen
Journal:  Clin Cancer Res       Date:  2014-03-19       Impact factor: 12.531

8.  Substrate stiffness effect and chromosome missegregation in hIPS cells.

Authors:  Suehelay Acevedo-Acevedo; Wendy C Crone
Journal:  J Negat Results Biomed       Date:  2015-12-18

9.  Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.

Authors:  W Günther; E Pawlak; R Damasceno; H Arnold; A J Terzis
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

10.  MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.

Authors:  Shu-Mei Chen; Hua-Chien Chen; Shu-Jen Chen; Chiung-Yin Huang; Pin-Yuan Chen; Tai-Wei Erich Wu; Ly-Ying Feng; Hong-Chieh Tsai; Tai-Ngar Lui; Chuen Hsueh; Kuo-Chen Wei
Journal:  World J Surg Oncol       Date:  2013-04-17       Impact factor: 2.754

View more
  3 in total

1.  The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.

Authors:  A M Cuesta; V Albiñana; E Gallardo-Vara; L Recio-Poveda; I de Rojas-P; K Villar Gómez de Las Heras; D T Aguirre; L M Botella
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

2.  Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line.

Authors:  Sabrina Francesca Samuel; Alistair James Marsden; Srihari Deepak; Francisco Rivero; John Greenman; Pedro Beltran-Alvarez
Journal:  Proteomes       Date:  2018-10-20

3.  Can ECIS Biosensor Technology Be Used to Measure the Cellular Responses of Glioblastoma Stem Cells?

Authors:  Laverne Diana Robilliard; Jane Yu; Sung-Min Jun; Akshata Anchan; Graeme Finlay; Catherine E Angel; Euan Scott Graham
Journal:  Biosensors (Basel)       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.